On the afternoon of April 24, Jian Rui, secretary of the municipal party committee, and Gao Hongbin, mayor of the city, met with Samir Agwal, vice president of global strategy of the Fresenius Kabi Group in Germany, and his party.
Fresenius Kabi Group is a wholly-owned subsidiary of the Fresenius Group of Germany, a Fortune 500 company. The Fresenius Group is a large multinational enterprise involving pharmaceuticals, nutrition, medical devices, hospital management and other medical and health related industries. As one of the important branches of the group, Fresenius Kabi Group, which focuses on providing clinical nutrition and fluid treatment for severe and chronic patients, is a global leader in this field, and the group has set up research and development centers and production bases in Beijing, Wuhan, Nanchang and other places, and achieved sales revenue of 7 billion yuan in China last year.
A few days ago, the development technology of the new dosage form of sustained-release anesthesia analgesic drugs innovatively developed by Liaoning Zhonghaikang Pharmaceutical Co., Ltd., a Chinese pharmaceutical capital enterprise, aroused the great attention of Fresenius Scarbi Group, and sent Mr. Samir Agwal to Visit And Discuss Cooperation in Zhonghaikang Pharmaceutical.
At the meeting, Jian Rui said that Liaoning Zhonghaikang Pharmaceutical Co., Ltd. was an important project that was settled in at the beginning of the construction of China's pharmaceutical capital, and the Benxi Municipal Party Committee and the Municipal Government have been giving strong support. This is an enterprise that aspires to achieve a career, and has a high-tech R & D team, and many pharmaceutical companies are currently benefiting from the R&D results of this team. Jian Rui said that the Benxi Municipal Party Committee and the Municipal Government are very much looking forward to the smooth negotiation and successful cooperation between the two sides, and are ready to provide excellent services for the cooperation between the two sides and promote the industrialization of the cooperation results of the two sides in China Pharmaceutical. At the same time, it is also expected that more large German enterprises will come to Benxi to invest in the future and accelerate the scale and internationalization of China's pharmaceutical capital.
Samir Agwal said that he has conducted in-depth and frank exchanges with Liaoning Zhonghaikang Pharmaceutical and reached a preliminary consensus on cooperation. Through the visit and inspection, I felt that the provincial and municipal leaders had open thinking and broad vision, and achieved extraordinary achievements in promoting the construction of China's pharmaceutical capital. It is hoped that the negotiation and meeting between the two sides can achieve substantive results and contribute to the construction and development of Yaodu.
Yu Hai, a deputy municipal cadre, attended the meeting.